Home:
PCU2|2002: Anthony
V D’Amico, MD, PhD: Select
publications
Select publications
The Medical Research Council Prostate Cancer Working Party
Investigator Group. Immediate versus deferred treatment for advanced
prostatic cancer: Initial results of the Medical Research Council
trial. Br J Urol 1997;79:235-246. Abstract
Bolla M et al. Improved survival in patients with locally
advanced prostate cancer treated with radiotherapy and goserelin.
N Engl J Med 1997;337:295-300. Abstract
D'Amico A. Radiation and hormonal therapy for locally
advanced and clinically localized prostate cancer. Urology
2001;58(2 Suppl 1):78-82. Abstract
Gleave ME et al. Randomized comparative study of 3- versus
8-month neoadjuvant hormonal therapy before radical prostatectomy:
Biochemical and pathological effects. J Urol 2001;166:500-6.
Abstract
Messing EM et al. Immediate hormonal therapy compared
with observation after radical prostatectomy and pelvic lymphadenectomy
in men with node-positive prostate cancer. New Engl J Med
1999;341:1781-1. Abstract
Pound CR et al. Natural history of progression after PSA
elevation following radical prostatectomy. JAMA 1999;281:1591-7.
Abstract
Roach III M et al. Neoadjuvant hormonal therapy (NHT)
with whole-pelvic (WP) radiotherapy (RT) improves progression-free
survival (PFS): RTOG (Radiation Therapy Oncology Group) 9413, a
phase III randomized trial. Proc ASCO 2002; No abstract
available.
Smith MR et al. Pamidronate to prevent bone loss during
androgen-deprivation therapy for prostate cancer. N Engl
J Med 2001;345:948-55. Abstract
Soloway MS et al. Neoadjuvant androgen ablation before
radical prostatectomy in cT2bNxMo prostate cancer: 5-year results.
J Urol 2002; 167:112-6. Abstract
|
